You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Momelotinib: an emerging treatment for myelofibrosis patients with anemia
|
|---|---|
| Published in |
Journal of Hematology & Oncology, January 2022
|
| DOI | 10.1186/s13045-021-01157-4 |
| Pubmed ID | |
| Authors |
Helen T. Chifotides, Prithviraj Bose, Srdan Verstovsek |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 21% |
| Spain | 4 | 17% |
| Germany | 2 | 8% |
| Uganda | 1 | 4% |
| Mexico | 1 | 4% |
| Algeria | 1 | 4% |
| Brazil | 1 | 4% |
| Switzerland | 1 | 4% |
| Unknown | 8 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 67% |
| Scientists | 6 | 25% |
| Practitioners (doctors, other healthcare professionals) | 2 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 57 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 4 | 7% |
| Researcher | 4 | 7% |
| Student > Ph. D. Student | 4 | 7% |
| Student > Bachelor | 3 | 5% |
| Student > Postgraduate | 3 | 5% |
| Other | 7 | 12% |
| Unknown | 32 | 56% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 8 | 14% |
| Medicine and Dentistry | 7 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 9% |
| Agricultural and Biological Sciences | 3 | 5% |
| Mathematics | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 31 | 54% |
Attention Score in Context
This research output has an Altmetric Attention Score of 151. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#278,915
of 25,815,269 outputs
Outputs from Journal of Hematology & Oncology
#18
of 1,309 outputs
Outputs of similar age
#8,179
of 521,099 outputs
Outputs of similar age from Journal of Hematology & Oncology
#1
of 20 outputs
Altmetric has tracked 25,815,269 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,309 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 521,099 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.